148 related articles for article (PubMed ID: 35771264)
1. A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif
Liu G; Xue J; Wang Y; Liu Z; Li X; Qu D; Su Z; Xu K; Qu X; Qu Z; Sun L; Cao M; Wang Y; Chen X; Yu J; Liu L; Deng Q; Zhao Y; Zhang L; Yang H
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2585-2593. PubMed ID: 35771264
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
3. A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects.
Xu Z; Wang Y; Liu Z; Zhang R; Zhou Y; Yu J; Lan J; Liang W; Liu G; Qu X; Chen J; Su Z; Yu S; Cheng Y; Wang W; Ren Q; Deng Q; Zhao Y; Yang H
Int Immunopharmacol; 2022 Aug; 109():108780. PubMed ID: 35461158
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Safety Comparison of 2 Afatinib Dimaleate Tablets in Healthy Chinese Volunteers Under Fasted Conditions: A Randomized, Open-Label, 2-Period, Single-Dose Crossover Study.
Shi P; Jiang X; Tao Y; Li T; Li X; Wang C; Liu Y; Ma Y; Gao X; Cao Y
Clin Pharmacol Drug Dev; 2022 Oct; 11(10):1177-1183. PubMed ID: 35794080
[TBL] [Abstract][Full Text] [Related]
5. Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial.
Xu Z; Liu Z; Wang Y; Xue J; Chang T; Cui Y; Cheng Y; Liu G; Wang W; Zhou Y; Yu S; Ren Q; Yang W; Qu X; Chen J; Chen X; Deng Q; Yang H; Wang X
Expert Rev Clin Pharmacol; 2023 Apr; 16(4):363-370. PubMed ID: 36883362
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang
Sun ML; Liu HJ; Luo XD; Wang Y; Zhang W; Liu C; Wang X
Drugs R D; 2022 Mar; 22(1):51-60. PubMed ID: 35061235
[TBL] [Abstract][Full Text] [Related]
7. A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.
Xu Z; Wang Y; Liu G; Chen J; Wang W; Cheng Y; Ren Q; Cui Y; Yang W; Liu Z; Chen X; Xue J; Chang T; Qu X; Yu S; Zhou Y; Xu K; Su Z; Deng Q; Zhao Y; Yang H
Expert Opin Investig Drugs; 2022 Jul; 31(7):737-746. PubMed ID: 35427205
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioequivalence of two pomalidomide capsules in healthy chinese subjects under fasting and fed conditions.
Liu Z; Xu Z; Gao Z; Ren Q; Chang T; Xue J; Yang H
Invest New Drugs; 2023 Feb; 41(1):60-69. PubMed ID: 36441437
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with breast, colorectal or gastric cancer under fed condition: A multicentric, randomized, open-label, single-dose, two-period, two-way crossover clinical trial.
Ma H; Zhao N; Luo S; Zhang Y; Yuan Z; Sun H; Gao S; Zhan X; Zhang L
Eur J Pharm Sci; 2023 Mar; 182():106373. PubMed ID: 36623698
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects.
Liu Z; Gao Z; Yang W; Zhang L; Xiao N; Qu D; Su Z; Xu K; Liu G; Wang Y; Ren Q; Yu S; Cheng Y; Zhou Y; Deng Q; Zhao Y; Wang Z; Yang H
Expert Opin Drug Metab Toxicol; 2022; 18(7-8):519-527. PubMed ID: 35961948
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of a Generic Nateglinide Formulation in Healthy Chinese Volunteers under Fasting and Fed Conditions: A Randomized, Open-Label, Double-Cycle, Double-Crossover Study.
Yu M; Li X; Jin H; Chen L; Wang N; Wang H; Cao Y; Sui X; Gao X; Yang H; Wang W
Pharmacology; 2021; 106(7-8):418-425. PubMed ID: 33866315
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.
Lin PP; Wang CJ; Liu YP; Li T; Gao XM; Ma YP; Shi P; Li X; Wang LX; Cao Y
Adv Ther; 2021 Feb; 38(2):1130-1142. PubMed ID: 33340343
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects.
Wang Y; Xue J; Su Z; Cui Y; Liu G; Yang W; Liu Z; Chen J; Ren Q; Yu S; Cheng Y; Zhou Y; Wang W; Chen X; Qu D; Deng Q; Zhao Y; Yang H
Expert Opin Investig Drugs; 2023 Mar; 32(3):263-270. PubMed ID: 36757390
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions.
Li T; Liu YP; Liu SQ; Shi P; Jiang X; Tao Y; Gao XM; Ma YP; Cao Y
BMC Pharmacol Toxicol; 2022 Jul; 23(1):45. PubMed ID: 35794660
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
